Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to buy: Nagaraj Shetti recommends IFCI, Five-Star Business Finance shares to buy in the short-term - livemint.com
Stocks to buy: Nagaraj Shetti recommends IFCI, Five-Star Business Finance shares to buy in the short-termlivemint.com
Yash's Toxic Unveils 'Ladies & Ladies' Teaser Featuring Star-Studded Female Cast
Shot in Kannada and English, the film will also be dubbed in Hindi, Tamil, Telugu and Malayalam.
BSE 500 stocks: Adani Ports, Marico, Ather, Piramal Finance hit new highs
Adani Enterprises, Aurobindo Pharma, GMR Airports, Gujarat Flurochemicals, Oracle Financial Services and Star Health Insurance from BSE 500 stocks registered 52-week highs on Wednesday.
Disney pumps Rs 123 crore into JioStar India in fresh FDI
Walt Disney's Star Group injected Rs 123 crore into JioStar India via FDI, bolstering the Reliance-Disney joint venture. This follows substantial prior investments by Disney, totaling Rs 3,847 crore in the current fiscal year. Despite reporting equity losses from the venture, Disney's continued financial commitment highlights its strategic interest in the Indian media landscape. The information and broadcasting sector saw significant FDI inflows during the quarter.
Strides Pharma Announces Stake Divestment Deal | Godrej Industries Strengthens Subsidiary with Funding | Top Buzzing Stocks Today - Equitymaster
Strides Pharma Announces Stake Divestment Deal | Godrej Industries Strengthens Subsidiary with Funding | Top Buzzing Stocks TodayEquitymaster
Strides Pharma Announces Stake Divestment Deal | Godrej Industries Strengthens Subsidiary with Funding | Top Buzzing Stocks Today - Equitymaster
Strides Pharma Announces Stake Divestment Deal | Godrej Industries Strengthens Subsidiary with Funding | Top Buzzing Stocks TodayEquitymaster
Strides Pharma rises after divesting stake in Pivot Path to Ascent Capital consortium
Strides Pharma Science added 2.69% to Rs 1112.30 after the company announced a strategic investment by a consortium led by Ascent Capital, along with co investor Vintage Classic, in its wholly owned subsidiary, Pivot Path.
Niva Bupa, Star Health Get Buy Calls As Nomura Initiates On Four Insurers -- Check Target Prices
Nomura initiated coverage on India's non-life insurance sector with Buy ratings on Niva Bupa and Star Health, while assigning Neutral ratings to ICICI Lombard and PB Fintech amid regulatory uncertainty.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Welcome To The Jungle Box Office Collection Day 3: Akshay Kumar's Star-Studded Comedy Sees Healthy Response
Welcome To The Jungle opened to a decent response and benefited from its franchise value, star-studded cast and family-friendly appeal.
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 crore
Strides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital and Vintage Classic. This strategic move aims to accelerate Pivot Path's growth by infusing Rs 50 crore for future expansion. Strides will retain a 19.95% stake, while the investors will hold 65.05%. The transaction values Pivot Path at Rs 230 crore post-money.
Strides Pharma to monetise stake in Pivot Path; company valued at ₹230 crore post-money
Strides Pharma Science Limited will monetise its stake in subsidiary Pivot Path Private Limited in a transaction led by Ascent Capital, alongside co-investor Vintage Classic, valuing the entity at near ₹230 crore post-money. The company will realise near ₹100 crore while retaining near 20% ownership and also receive a primary capital infusion of ₹50 crore into the business.